Off-label use of psychotropic medications in paediatric wards: A prospective study;Utilisation hors autorisation de mise sur le marché (AMM) des psychotropes en pédiatrie : une étude prospective

Archives de Pediatrie

Volumn 16, Issue 9, 2009, Pages 1252-1260

  Winterfeld, U ^a   Le Heuzey, M F ^a   Acquaviva, E ^a   Mouren, M C ^a   Brion, F ^a   Bourdon, O ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; CLOBAZAM; DIAZEPAM; HYDROXYZINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; RISPERIDONE;

ADOLESCENT; ANXIETY; ARTICLE; CHILD; CONTROLLED STUDY; DISRUPTIVE BEHAVIOR; DRUG UTILIZATION; FEMALE; FRANCE; HOSPITAL PHARMACY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OFF LABEL DRUG USE; PAIN; PEDIATRIC WARD; PRESCRIPTION; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TEACHING HOSPITAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALS, PEDIATRIC; HOSPITALS, TEACHING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MENTAL DISORDERS; OFF-LABEL USE; PARIS; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS;

EID: 68549134910     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2009.06.012     Document Type: Article

References (30)

1. Cuzzolin L., Atzei A., and Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 5 (2006) 703-718
2. Assion H.J., and Jungck C. Off-label prescribing in a German psychiatric hospital. Pharmacopsychiatry 40 (2007) 30-36
3. Haw C., and Stubbs J. A survey of the off-label use of mood stabilizers in a large psychiatric hospital. J Psychopharmacol 19 (2005) 402-407
4. Martin R.M., Wilton L.V., Mann R.D., et al. Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label. BMJ 317 (1998) 204
5. Efron D., Hiscock H., Sewell J.R., et al. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 111 (2003) 372-375
6. Hugtenburg J.G., Heerdink E.R., and Tso Y.H. Psychoactive drug prescribing by Dutch child and adolescent psychiatrists. Acta Paediatr 94 (2005) 1484-1487
7. Nahata M.C. Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother 33 (1999) 247-249
8. D'Amato G. Chlordiazepoxide in the management of school phobia. Diseas Nerv System 23 (1962) 293-295
9. Kraft I.A., Ardali C., Duffy J.H., et al. A clinical study of chloridazepoxide used in psychiatric disorders of children. Int J Neuropsychiatry 1 (1965) 433-437
10. Kutcher S.P., Reiter S., Gardner D.M., et al. The pharmacotherapy of anxiety disorders in children and adolescents. Psychiatr Clin North Am 15 (1992) 41-67
11. Simeon J.G., Ferguson H.B., Knott V., et al. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 31 (1992) 29-33
12. Graae F., Milner J., Rizzotto L., et al. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33 (1994) 372-376
13. Petti T.A., Fish B., Shapiro T., et al. Effects of chlordiazepoxide in disturbed children: a pilot study. J Clin Psychopharmacol 2 (1982) 270-273
14. Barnes M.P. Management of spasticity. Age Ageing 27 (1998) 239-245
15. Gracies J.M., Nance P., Elovic E., et al. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 6 (1997) S92-120
16. Groves L., Shellenberger M.K., and Davis C.S. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Adv Ther 15 (1998) 241-251
17. Fish B. Drug therapy in child psychiatry: pharmacological aspects. Compr Psychiatry 1 (1960) 212-227
18. Shapira J., Kupietzky A., Kadari A., et al. Comparison of oral midazolam with and without hydroxyzine in the sedation of pediatric dental patients. Pediatr Dent 26 (2004) 492-496
19. Jensen P.S., Buitelaar J., Pandina G.J., et al. Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials. Eur Child Adolesc Psychiatry 16 (2007) 104-120
20. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev (2007) CD005454
21. Vignatelli L., D'Alessandro R., and Candelise L. Antidepressant drugs for narcolepsy. Cochrane Database Syst Rev (2005) CD003724
22. Papatheodorou G., Kutcher S.P., Katic M., et al. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol 15 (1995) 110-116
23. West S., Keck P.E.J., and McElroy S.L. Open trial of valproate in the treatment of adolescent mania. J Child Adolesc Psychopharmacol 4 (1994) 263-267
24. Deltito J.A., Levitan J., Damore J., et al. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients. Acta Psychiatr Scand 97 (1998) 236-240
25. Wagner K.D., Weller E.B., Carlson G.A., et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 41 (2002) 1224-1230
26. Pavuluri M.N., Henry D.B., Carbray J.A., et al. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 7 (2005) 266-273
27. Chang K.D., Dienes K., Blasey C., et al. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry 64 (2003) 936-942
28. Donovan S.J., Stewart J.W., Nunes E.V., et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry 157 (2000) 818-820
29. Steiner H., Petersen M.L., Saxena K., et al. Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. J Clin Psychiatry 64 (2003) 1183-1191
30. Biederman J., Swanson J.M., Wigal S.B., et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics 116 (2005) e777-e784